| Mr Robert David Ure, MD | |
|
4738 Little Road, Arlington, TX 76017 | |
| (817) 483-8599 | |
| (817) 483-2440 |
| Full Name | Mr Robert David Ure |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | 4738 Little Road, Arlington, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306914148 | NPI | - | NPPES |
| 035737804 | Medicaid | TX | |
| 035737803 | Medicaid | TX | |
| 035737802 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | F2978 (Texas) | Primary |
| Entity Name | Wellmed Medical Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437156486 PECOS PAC ID: 4880657386 Enrollment ID: O20041105000519 |
News Archive
Cancer Research Technology, the commercial arm of Cancer Research UK, has signed a license agreement to grant antibody medicines company, Affitech A/S, exclusive rights to a CRT patent application and relevant know how to develop and use therapeutic antibodies that recognise and block the function of CCR4, a protein found on certain tumours - including early and late stage cervical cancer and oesophageal cancer.
At the 2013 World Molecular Imaging Congress (WMIC, www.wmicmeeting.org), Bruker today introduces its ParaVision® 6 software, setting new standards in preclinical MRI software that delivers significantly enhanced productivity for both, routine users and accomplished experts. A redefined workflow introduces optimized, application-oriented experimental protocols, an intuitive, interactive 3D scan planning viewport, and automatic reporting. Thanks to its DICOM-based data exchange module, ParaVision 6 seamlessly integrates with data from multimodal imaging studies employed in many preclinical research labs.
Today, Bruegger's announced that it will donate approximately $90,000 to Children's Miracle Network Hospitals - largely the result of its "Bottomless Mug" campaign, which ran October 27, 2010 through January 31, 2011.
A breakthrough technique that allows scientists to view individually-labeled tumor cells as they move about in real time in a live mouse may enable scientists to develop microenvironment-specific drugs against cancer, researchers report at the American Society for Cell Biology (ASCB) 48th Annual Meeting, Dec. 13-17, 2008 in San Francisco.
Scientists have determined a three-dimensional (3-D) molecular image of how anthrax toxin enters human cells, giving scientists more potential targets for blocking the toxin, the lethal part of anthrax bacteria.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Robert David Ure, MD 4738 Little Road, Arlington, TX 76017 Ph: (817) 483-8599 | Mr Robert David Ure, MD 4738 Little Road, Arlington, TX 76017 Ph: (817) 483-8599 |
News Archive
Cancer Research Technology, the commercial arm of Cancer Research UK, has signed a license agreement to grant antibody medicines company, Affitech A/S, exclusive rights to a CRT patent application and relevant know how to develop and use therapeutic antibodies that recognise and block the function of CCR4, a protein found on certain tumours - including early and late stage cervical cancer and oesophageal cancer.
At the 2013 World Molecular Imaging Congress (WMIC, www.wmicmeeting.org), Bruker today introduces its ParaVision® 6 software, setting new standards in preclinical MRI software that delivers significantly enhanced productivity for both, routine users and accomplished experts. A redefined workflow introduces optimized, application-oriented experimental protocols, an intuitive, interactive 3D scan planning viewport, and automatic reporting. Thanks to its DICOM-based data exchange module, ParaVision 6 seamlessly integrates with data from multimodal imaging studies employed in many preclinical research labs.
Today, Bruegger's announced that it will donate approximately $90,000 to Children's Miracle Network Hospitals - largely the result of its "Bottomless Mug" campaign, which ran October 27, 2010 through January 31, 2011.
A breakthrough technique that allows scientists to view individually-labeled tumor cells as they move about in real time in a live mouse may enable scientists to develop microenvironment-specific drugs against cancer, researchers report at the American Society for Cell Biology (ASCB) 48th Annual Meeting, Dec. 13-17, 2008 in San Francisco.
Scientists have determined a three-dimensional (3-D) molecular image of how anthrax toxin enters human cells, giving scientists more potential targets for blocking the toxin, the lethal part of anthrax bacteria.
› Verified 8 days ago
Yen Nguyen, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 1321 E Pioneer Parkway, Arlington, TX 76010 Phone: 817-265-8777 Fax: 817-265-0802 | |
Brian J Caplan, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 3018 Oak Cove Rd, Arlington, TX 76017 Phone: 817-473-6191 Fax: 817-473-9873 | |
Dr. Nhan Chi Pham, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 912 E Park Row Dr, Arlington, TX 76010 Phone: 817-277-2977 Fax: 817-277-4750 | |
Germaine B Hawkins, DO General Practice Medicare: Accepting Medicare Assignments Practice Location: 2233 Avenue J Ste 101, Arlington, TX 76006 Phone: 817-460-7080 Fax: 817-460-1220 | |
Murray Robert Strauss, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 315 N Davis Dr Unit B, Arlington, TX 76012 Phone: 817-274-3737 Fax: 469-854-6862 | |
Dr. Larry D Sprowls, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 2301 North Collins, Arlington, TX 76011 Phone: 817-469-7171 Fax: 817-795-4255 |